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Abstract: Poor adherence to highly active antiretroviral therapy (HAART) is a major hindrance 
to the reduction of mortality and morbidity due to HIV . This qualitative study used focus groups 
to explore the views and experiences of HIV patients on HAART with adherence reminders, 
especially the text message (SMS [short message service]). The ethnographic data obtained 
were used to design a clinical trial to assess the effect of motivational text messages versus usual 
care to enhance adherence to HAART among HIV patients in Yaoundé, Cameroon. Participants 
appreciated the idea of a timely SMS reminder, and cited the physician as a role model. They 
expressed concerns about privacy. Long-term life goals were a motivating factor to adhere. 
Overall, text messaging was viewed positively as a tool with a dual function of reminder and 
motivator. Messages coming from the attending physician may have a stronger impact. Trials 
investigating the use of text messages to improve adherence to HAART need to consider the 
content and timing of SMS, taking into account technical challenges and privacy.
Keywords: focus groups, adherence, highly active antiretroviral therapy (HAART), text 
message, short message service (SMS), human immunodeficiency virus (HIV)
Introduction
Highly active antiretroviral therapy (HAART) has greatly reduced morbidity and 
mortality due to HIV .1 However, the battle is not yet won, as multiple barriers to 
adherence are common in all groups of people living with HIV .2 It was initially thought 
that near perfect adherence is an absolute necessity for optimal viral load suppression.3 
Recent findings suggest that some viral load suppression can occur at less that 95% 
adherence, even though this may depend on the specific regimen, the duration of 
follow-up, and the way adherence is measured.4–6 Poor adherence is a gateway for 
the development of drug-resistant strains of HIV .4,7 It is also associated with disease 
progression and mortality.8,9 Generally speaking, high rates of adherence are desirable 
and should be promoted. It is of particular importance to investigate ways of improving 
adherence by providing support and counseling, sending reminders, or using easy-to-
take regimens. However, the literature on aids to adherence in resource-limited settings 
is rather scarce, and most often involves interpersonal techniques like encouragement, 
medication delivery, nutrition, and housing support.10
Adoption and use of mobile phone technology is experiencing its greatest growth 
rate in Africa.11 The mobile phone text message, or SMS (short message service), has 
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been investigated as a tool for improving adherence to 
HAART, in different settings, with different message timings 
and content.12–14
The Cameroon Mobile Phone SMS (CAMPS) trial 
(ongoing) is investigating the use of weekly motivational 
mobile phone text messages to improve adherence to HAART 
in Cameroon.15 This paper investigates clients’ perception 
of their difficulties with adherence, the applicability of the 
intervention, and how it can be adapted to the local setting. 
As the literature on the use of mobile phone technology to 
improve adherence to HAART is growing, its applicability 
will depend not only on its efficacy but also on how well 
it responds to clients’ needs. Before testing the efficacy of 
the SMS, a broader sense of its utility, content, and timing 
is required.
We used focus group discussions with participants drawn 
from the waiting rooms of the Yaoundé Central Hospital 
(YCH) Accredited Treatment Centre (ATC), a large urban 
HIV clinic, and collected data from clients. The overall aim 
of the interviews was to investigate patient experiences with 
adherence and adherence reminders focusing on the use of 
the SMS as a potential reminder. We also explored patient 
views on the content of the text message, role models as 
motivators to take medication, personal motivating factors 




We based our research on the premise that humans have free 
will and strive to achieve their maximum potential, even 
though external help is often necessary (humanism).16 In 
broad terms, our research investigates the individual living 
with HIV and a specific intervention to improve adherence 
to medication and thus health and well-being. We used 
ethnographic methods to capture and interpret the phenomena 
surrounding adherence to medication, with specific focus 
on the SMS as a potential tool. The ethnographic approach 
was deemed significant for this study because of its focus 
on groups (people living with HIV) and its ability to eluci-
date lifestyles (adherence), within the subcultural context 
in which they are enacted.17 Our findings are the results of 
direct contact with group members.
Ethical considerations
We obtained permission to conduct the interviews from 
the administration the YCH-ACT. Ethical clearance was 
obtained from the Cameroon National Ethics Committee. 
Following the discussions about the purpose of the study, 
we obtained verbal consent from all patients who volunteered 
to participate in the focus groups. Persons aged below 
21 years were not included, as they were below the age of 
legal consent. They were assured of protection of privacy, 
confidentiality, and anonymity in reporting the results of the 
focus group. The notes were taken in a register, which was 
kept in a secure location.
Precollection material
We developed a group discussion guide listing specific 
topics to be addressed and providing a framework for the 
moderator to ask questions (Table 1). This guide covered 
questions related to difficulties with adherence, timeliness 
of medication taking, reminders, content of the text message, 
role models as motivators to take medication, personal 
motivating factors to adhere, and practical issues concerning 
the use of the SMS. The guide was reviewed by a group of 
experts that included two anthropologists, a sociologist, and 
the moderator of the group discussions. We pilot tested it on 
five volunteers for clarity. The guide ensured that the same 
themes were covered in all the group discussions.
Study setting
The YCH-ATC is the largest HIV clinic in the country, with 
about 40 new patients every week and 6500 regular clients. 
Waiting times at the YCH-ATC vary from 30 minutes to 
2 hours, based on arrival time and physician   availability. 
There are hundreds of patients waiting for as few as eight 
  physicians. Yaoundé is the capital city of Cameroon, situated in 
Table 1 Focus group discussion guide
Adherence
Do you have difficulties in taking your medication?
Do you sometimes miss doses?
What can make you miss a dose?
Is there any way the hospital can help you to improve your adherence?
Do you have any specific ways to improve your adherence?
Do you think any of these approaches work?
The SMS
What do you think about use of SMS as a reminder strategy?
When and how often do you think SMS should be sent?
What kind of message do you think would be useful if one were to use 
SMS as a reminder tool?
Role models
Do you have a role model?
Who is your role model?
Do you think having an SMS message associated with this individual 
could be an effective motivator to help people adhere to treatment?
Life goals and motivation to take medication
What motivates you to take your medication?
What are your top goals for the next 5 years?
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the center region and comprising a mostly urban community. 
In 2004, the prevalence of HIV in Yaoundé was estimated 
to be 8.3%.18
Data collection
Clients found in the waiting room were approached by the 
interviewer and asked whether they were willing to discuss 
their adherence to HAART. Consenting persons were then 
grouped in a separate room free from external distractions 
and interviewed. The interview team was made up of an 
experienced moderator (a medical anthropologist) and a 
note-taker, both in plain clothes and neither of whom was 
staff of the hospital. Five group interviews were performed 
during the period October 15–19, 2010. Interviews lasted 
between 45 minutes and 60 minutes and were conducted in 
French. Participants were seated such that they could see 
each other and the moderator. Discussions were based on 
open-ended thematic questions prespecified in the group 
discussion guide. The moderator asked additional questions 
to clarify specific areas of interest. Despite the interview tak-
ing place in a hospital setting, participants freely discussed 
the problems they had with adherence and how the SMS 
could help. The participants were identified by their groups 
and individual numbers. Only gender was noted. All treat-
ment regimens provided at the time of this study were twice-
daily regimens. We carried out group discussions using the 
discussion guide to keep the responses from derailing from 
our topics of interest, and stopped the discussions when no 
new ideas were forthcoming. Once saturation was met, the 
notes were read to the participants to ensure accuracy and to 
confirm the quotes. Data collection was set to end when no 
new ideas where forthcoming, thus delimiting our sample 
size. Qualitative samples are often small and data gathering 
usually stops when no new information can be obtained.19
The participants
The participants were selected from the YCH-ACT. By so 
doing we obtained information from people belonging to the 
parent sample from which the CAMPS trial would recruit and 
who had experience with the phenomenon under study. No 
hospital staff were involved in the recruitment or interview-
ing process. We included patients who were HIV positive, 
regularly received treatment from the YCH-ACT irrespective 
of the duration, were present in the waiting room on the days 
of the group discussions, and were willing to participate. 
Verbal consent was a prerequisite to recruitment. We excluded 
patients who were not regulars at the clinic and those aged 
less than 21 years.
Thirty-two people participated in six group discussions. 
The average group size was five people. We considered only 
participants who took part in the discussions from start to 
finish, excluding those who left midway or joined the group 
later on. Two people were excluded from the analysis on this 
basis. The small groups permitted the moderator to elicit 
responses from everyone. Two-thirds of the population were 
women. The common characteristic of the participants was 
that they were all living with HIV and taking HAART from 
the same clinic. They were a subset of the population from 
which we wished to obtain information and could provide 
insights into the challenges they faced with adherence, 
reminder mechanisms, and motivation to adhere.
Data analysis
Data were analyzed for 30 participants. Analysis was limited 
to the content of the discussions. A verbatim transcript of the 
discussion was noted in a register by the note-taker. Coding 
was done manually by placing the data into categories, based 
on the themes in the discussion guide, namely adherence, text 
message reminders, role models, life goals, and motivation. 
RCBM coded the data. They were verified by LM. RCBM, 
LM, and LT verified the manuscript for consistency with the 
original notes. Disagreements were resolved by discussion.
Results
We included 19 females and eleven males. All were aged 
21 years or above and resided in the Yaoundé. They were all 
taking HAART from the same clinic (YCH-ACT).
Adherence
Adherence was deconstructed using questions investigating 
difficulty in taking medication, timeliness of taking medica-
tion, and personal approaches to improving adherence.
A third (ten of 30) of the patients declared that they had 
some difficulty in following the prescribed medication. 
They claimed that their adherence improved with time and 
“experience”. There was an initial period of forgetfulness 
at the onset of therapy, and then later on the medication 
became more habitual. Missed doses were caused by inci-
dental events like journeys and running out of pills. Financial 
difficulties leading to inability to afford regular meals were 
also raised as a reason for not taking medication. Some 
reported being abandoned by their family members, poor 
clinical response to medication, and side effects as reasons 
for missing doses.
Most of the participants (17 of 30) acknowledged 
not being able to take medication on time, with a delay 
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time varying from a few minutes to several hours, and 
appreciated the idea of a reminder. Only a quarter (seven 
of 30) of the patients had a systematic reminder method 
for their medication. They felt that it would establish a 
new routine and remove the stress of having to remember 
when to take medication, leaving the responsibility to 
external forces. For those who used reminders, they cited 
alarms, meal times, mobile phone beeps from close ones, 
personal verbal reminders by individuals, and prayer times 
for Muslims.
“I have no problem, I just use prayer hours. ” (Group 2, 
Participant 4)
Their most preferred reminders were beeps, alarms, text 
messages, or personal verbal reminders from their entourage. 
Preferences for the different types of reminders varied greatly 
among the participants.
“I forgot my telephone at home. I would prefer something 
I can hang around my neck. ” (Group 1, Participant 3)
“… I set my telephones to remind me …” (Group 3, 
Participant 6)
A few described the difficulties they faced with the cur-
rent methods they were using.
“I set my phone to ring when I am supposed to take my 
medication, but sometimes I don’t hear it. ” (Group 3, 
Participant 3)
“Sometimes I am 30 minutes late. ” (Group 2,   Participant 1)
“You should provide counseling to encourage patients.” 
(Group 4, Participant 2)
The SMS
Half (15 of 30) of the participants believed that the SMS 
could help them take their medication but that the value of 
the SMS would depend on the sender. Some preferred that 
the SMS should come from their physician.
“I think it’s a good idea. ” (Group 5, Participant 7)
There was no consensus as to the content of the 
message.
“It’s time to take your medication. ”  (Group  1, 
Participant 3)
“The content is not important. ” (Group 1,   Participant 4)
“A beep is sufficient because there are people who go 
through other people’s phones. ” (Group 3, Participant 2)
“Call to order. ” (Group 1, Participant 1)
“It’s time. ” (Group 1, Participant 1)
  “The SMS may expose the privacy of the patient; therefore, 
not everyone should be able to understand it. ” (Group 5, 
Participant 6)
“The SMS should be coded. ” (Group 2, Participant 4)
The number of messages participants wanted also varied. 
Some preferred to receive two messages – one in the morning 
and in the evening. Others preferred to receive four messages 
per day: ie, 15 minutes before time and one exactly on time 
for medication (twice daily).
Role models
Very few patients declared to have role models. Only three 
of the 30 participants declared to have role models and found 
the idea of using role models as message senders interest-
ing. However, most still preferred to have the message come 
from their physician, and identified him/her as the figure they 
looked up to. The three who had role models each had a differ-
ent one Samuel Eto’o Fils (soccer player), Akon (musician,) 
and Barack Obama (US President).
“My idol is Eto’o. A message coming from him would be 
good!” (Group 2, Participant 1)
“I don’t have a role model, so for me it is not   interesting. ” 
(Group 6, Participant 7)
“Role models are good in motivating people to take their medi-
cation. For example, when Barack Obama went to Kenya he 
did a public HIV screening test and it motivated many Kenyans 
to do screening tests. ” (Group 7, Participant 7)
Life goals and motivation to take 
medication
For most participants, their motivation to take medication 
was based on the hope of finding a cure sometime in the 
future, or the fear of falling sick. Some expressed the desire 
to achieve personal goals such as having kids, raising their 
kids, and building houses.
“When I see how other people on medication are   faring well, 
it motivates me to take mine too. ” (Group 3,   Participant 4)
“I don’t have any side effects. This motivates me to take my 
medication. ” (Group 2, Participant 2)
Additional issues
We also recorded additional comments of interest. Some par-
ticipants brought up pertinent points regarding the use of text 
messages, such as poor network, possibility of dependence 
on the SMS, and poor adherence in its absence.
“There is no network in my quarter!” (Group 3, 
  Participant 1)
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Discussion
This paper directly explores the issues surrounding the use 
of mobile phone text messages to improve adherence to 
HAART among people living with HIV , and raises serious 
questions concerning the applicability of such a technique 
in low-resource settings. We collected data from the focus 
groups until we achieved data saturation: ie, no new ideas 
were forthcoming.
The interviewer and note-taker played a central role in 
the data collection process. They have experience with eth-
nographic research in the same clinic and knowledge of the 
dynamics within the environment. They employed personal 
empathy to put the participants at ease and hence be more 
willing to divulge information. Their relationships with the 
participants were not affected by status or conflicting roles, 
as they were not medical or social staff of the clinic.
The overall impression is that participants appreciated 
the idea of a text message reminder, if it was timely enough, 
  irrespective of the content. The physician was the figure they 
identified with the most as a role model. They expressed con-
cerns about privacy and the possibility of disclosure of status. 
Long-term goals stood out as additional motivation to take 
  treatment. We also identified a clear need for support from peers, 
family, or health personnel. Poor mobile provider services may 
hinder the technical applicability of such an intervention.
Despite the nearly ubiquitous nature of the mobile phone, 
its formal application to improve adherence to HAART is 
relatively new. A study in India found that participants were 
very interested in mobile phones for improving adherence to 
HAART, and often used their phones to contact their health 
provider.20 In this study, disclosure of status was not a deter-
rent to the use of text messages.20 A systematic review on 
the use of mobile phone technology in South Africa found 
that it could play an important role in the control of HIV/
AIDS by supporting adherence and other interventions.21 In 
a survey of HIV-positive patients in Ghana, a majority of the 
patients agreed that a mobile phone-based reminder system 
would be helpful in improving adherence to HAART.22 HIV-
positive patients were also willing to use their mobile phones 
to receive reminder text messages in Peru.23
The potential role that the SMS can play need not under-
mine the importance of family and peer support. Another 
ethnographic study reports additional motivation to adhere 
beyond the desire to be healthy but rather to conserve social 
capital.10 This highlights the role that peers and family can 
play in promoting adherence.
The implications of such findings to the conduct of a text 
message trial are clear. As a reminder, text messages and 
beeps may be helpful. For motivational purposes, role models 
may not work. The paternalistic approach to medicine is still 
prevalent in this context and may explain the important posi-
tion of the physician as a potential role model.24 Measures to 
protect privacy and disclosure of status should be employed. 
Impersonal messages may help to protect privacy, but on 
the other hand may lose the motivational effect that can be 
obtained by personalization. Building on long-term goals, 
motivations, and family ties can provide new avenues for 
improving adherence.
Lessons learnt for the CAMPS trial
Based on the information obtained from this study, the 
CAMPS trial did not use role models to motivate participants 
to adhere to HAART.15 They used empathic and friendly 
messages inviting the participants to report any difficulties 
with medication. Different messages were sent on a weekly 
basis. The content of the message did not disclose HIV status 
or the kind of medication taken. These messages were sent 
from the research center and were not outsourced to a mobile 
phone company. A phone number was provided for trial par-
ticipants who wished to talk to a physician. The CAMPS trial 
also used the delivery report function to determine whether 
the messages were received.
Limitations
This study has some limitations that are worth noting. The open 
nature of the interviews may have caused some participants 
to reserve their comments. We also think that patients may be 
uncomfortable with discussions about adherence in the hospital 
setting, even though we endeavored to make the interviews 
as informal as possible using plain-clothed and nonstaff 
  interviewers. To reassure the participants of confidentiality 
and anonymity, only gender-related information was collected. 
Age was used only to determine eligibility. Additional sociode-
mographic data were not collected, because the participants in 
this study and the participants in the CAMPS trial were drawn 
from the same population. We have no reason to believe that 
these two groups will differ significantly as to create concerns 
about external validity. We cannot ascertain that these findings 
would apply in a different setting. Finally, notes were taken 
manually (without a video or audio recorder). Even though 
the quotes were reread to the participants to ensure accuracy, 
there is always the possibility of human error.
Conclusion
People living with HIV experience difficulties related to 
treatment and need support in order to adhere to treatment. 
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The text message is an acceptable means of providing support 
and motivation. How it can be tailored to suit individual needs 
or adapted to suit the majority of the patients is a subject for 
further research. The physicians’ status in this context can be 
used to encourage adherence. The possibility of disclosure 
of status, loss of privacy, and technical difficulties must also 
be addressed before text messages can be used on a large 
scale.
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